drugset / Trial / NCT00031395
Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
Phase 3
Completed
122 enrolled
University of Cincinnati
National Institute of Neurological Disorders and Stroke (NINDS) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety and efficacy of clonidine alone or in combination with methylphenidate for children 7-12 years of age with attention-deficit, hyperactivity disorder.
Timeline
- Start
- 1999-09
- Primary completion
- —
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clonidine | Other / unclassified | — | — |
| Comparator | Methylphenidate | Small molecule | — | — |